Cystadenocarcinoma
Showing 26 - 50 of 233
Pseudomyxoma Peritonei, Peritoneal Cancer, Mucinous Adenocarcinoma Trial (Bromelain, Acetylcysteine, Interventional radiology
Not yet recruiting
- Pseudomyxoma Peritonei
- +3 more
- Bromelain
- +2 more
- (no location specified)
Feb 28, 2022
Cytoreductive Surgery, Grade 3 Endometrial Endometrioid Adenocarcinoma, High Grade Serous Carcinoma Trial in Boston (PET/MRI
Not yet recruiting
- Cytoreductive Surgery
- +4 more
- PET/MRI with radiotracer ([18F]- fluorodeoxyglucose) and a gadolinium-based contrast agent
-
Boston, MassachusettsMassachusetts General Hospital
May 21, 2022
High Grade Serous Carcinoma, Triple Negative Breast Cancer, Ovarian Cancer Trial (Olaparib tablet, Navitoclax)
Recruiting
- High Grade Serous Carcinoma
- +2 more
- Olaparib tablet
- Navitoclax
-
Toronto, Ontario, Canada
- +2 more
Nov 28, 2022
Peritoneal Cancer, Pseudomyxoma Peritonei, Mucinous Adenocarcinoma Trial in Lexington, Stony Brook (nanoliposomal irinotecan)
Completed
- Peritoneal Cancer
- +7 more
- nanoliposomal irinotecan
-
Lexington, Kentucky
- +1 more
May 5, 2022
Endometrial Serous Adenocarcinoma, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in United States
Recruiting
- Endometrial Serous Adenocarcinoma
- +2 more
- Biopsy
- +3 more
-
Phoenix, Arizona
- +3 more
Feb 2, 2023
High Grade Fallopian Tube Serous Adenocarcinoma, High Grade Ovarian Serous Adenocarcinoma, Peritoneal High Grade Serous
Recruiting
- High Grade Fallopian Tube Serous Adenocarcinoma
- +5 more
- Lenvatinib
- Pembrolizumab
-
Houston, TexasM D Anderson Cancer Center
Jul 9, 2022
Recurrent Endometrial Serous Adenocarcinoma, Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma Trial in Aurora
Active, not recruiting
- Recurrent Endometrial Serous Adenocarcinoma
- +3 more
- Laboratory Biomarker Analysis
- +3 more
-
Aurora, ColoradoUniversity of Colorado Hospital
May 24, 2022
Colorectal Adenocarcinoma, Mucinous Adenocarcinoma, Signet Ring Cell Adenocarcinoma Trial in Trondheim, Lørenskog, Oslo
Not yet recruiting
- Colorectal Adenocarcinoma
- +2 more
-
Trondheim, Trondelag, Norway
- +2 more
Aug 15, 2022
High Grade Serous Carcinoma Trial in Baltimore, Boston, Philadelphia (Olaparib Pill, AZD6738)
Recruiting
- High Grade Serous Carcinoma
- Olaparib Pill
- AZD6738
-
Baltimore, Maryland
- +2 more
Mar 4, 2022
Mesothelioma, Mesotheliomas Pleural, Mesothelioma, Malignant Trial in Bethesda, Nashville (TC-510, Fludarabine,
Recruiting
- Mesothelioma
- +14 more
- TC-510
- +2 more
-
Nashville, TennesseeSarah Cannon Research Institute
Jul 14, 2022
Recurrent Endometrial Serous Adenocarcinoma Trial in Columbus (procedure, biological, drug)
Not yet recruiting
- Recurrent Endometrial Serous Adenocarcinoma
- Biospecimen Collection
- +4 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
May 12, 2023
Melanoma, Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma Trial in Australia (AI-061)
Not yet recruiting
- Melanoma
- +16 more
-
Darlinghurst, New South Wales, Australia
- +3 more
May 12, 2023
Mucinous Adenocarcinoma of the Rectum, Signet Ring Adenocarcinoma of the Rectum, Stage IIA Rectal Cancer Trial in Los Angeles
Active, not recruiting
- Mucinous Adenocarcinoma of the Rectum
- +7 more
- bevacizumab
- +4 more
-
Los Angeles, CaliforniaUSC Norris Comprehensive Cancer Center
Aug 5, 2022
Breast Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma Trial in Philadelphia (Metformin
Active, not recruiting
- Breast Carcinoma
- +4 more
- Metformin Hydrochloride
- Doxycycline
-
Philadelphia, PennsylvaniaThomas Jefferson University
Feb 28, 2022
Ovarian Tumor Epithelial, Ovarian Cancer, Fallopian Tube Tumors Trial in India (Oregovomab, Paclitaxel, Carboplatin)
Not yet recruiting
- Ovarian Neoplasm Epithelial
- +4 more
- Oregovomab
- +3 more
-
Visakhapatnam, Andhra Pradesh, India
- +7 more
Dec 7, 2022
Rectal Mucinous Adenocarcinoma, Rectal Signet Ring Cell Adenocarcinoma, Recurrent Rectal Carcinoma Trial in Houston (drug,
Terminated
- Rectal Mucinous Adenocarcinoma
- +8 more
- Capecitabine
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Nov 21, 2022
Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation, Endometrial Adenocarcinoma Trial in Houston (Copanlisib,
Recruiting
- Deleterious BRCA1 Gene Mutation
- +10 more
-
Houston, TexasM D Anderson Cancer Center
Aug 23, 2022
Malignant Solid Tumor, Ovarian Low Grade Serous Adenocarcinoma, Pancreatic Carcinoma Trial (Binimetinib, Biopsy, Biospecimen
Not yet recruiting
- Malignant Solid Neoplasm
- +4 more
- Binimetinib
- +6 more
- (no location specified)
Nov 8, 2022
Uterine Carcinoma Trial in New Hyde Park (Paclitaxel/Carboplatin, Pelvic radiation therapy)
Recruiting
- Uterine Carcinoma
- Paclitaxel/Carboplatin
- Pelvic radiation therapy
-
New Hyde Park, New YorkArisa Kapedani
Nov 16, 2021
Fallopian Tube Carcinosarcoma, Primary Peritoneal Carcinosarcoma, Recurrent Fallopian Tube Carcinoma Trial in Rochester (Biopsy,
Not yet recruiting
- Fallopian Tube Carcinosarcoma
- +14 more
- Biopsy
- +6 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jun 28, 2023
Endometrial Serous Adenocarcinoma Trial in United States (Biospecimen Collection, Resection, Triapine)
Recruiting
- Endometrial Serous Adenocarcinoma
- Biospecimen Collection
- +2 more
-
Coral Gables, Florida
- +5 more
Aug 23, 2022
Stage I Testicular Seminoma, Stage I Testicular Nonseminomatous Germ Cell Tumor, Gastrointestinal Stromal Tumors Trial in
Not yet recruiting
- Stage I Testicular Seminoma
- +13 more
- Oncological Follow-up
-
Amiens, France
- +2 more
Aug 12, 2022
BRCA1 Gene Mutation, BRCA2 Gene Mutation, Ovarian Serous Adenocarcinoma Trial in Buffalo, New York (biological, other, drug)
Active, not recruiting
- BRCA1 Gene Mutation
- +5 more
- Durvalumab
- +3 more
-
Buffalo, New York
- +1 more
Jan 20, 2023